Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study

Diabetology & Metabolic Syndrome

Cynthia Owsley⁴  Jinan Saaddine¹  C. Douglas Witherspoon⁴  Karen Searcey⁴  Koula Callahan⁴  Paul A. MacLennan⁵  Ambika P. Ashraf²  Gerald McGwin³  Jeffrey L. Tapley⁴ 

[1] Vision Health Initiative, Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta 30329, GA, USA;Department of Pediatrics/Division of Endocrinology, University of Alabama at Birmingham, Birmingham 35294, AL, USA;Department of Epidemiology, University of Alabama at Birmingham, Birmingham 35294, AL, USA;Department of Ophthalmology, University of Alabama at Birmingham, Birmingham 35294, AL, USA;Department of Surgery, University of Alabama at Birmingham, Birmingham 35294, AL, USA

关键词: Visual acuity;    Pediatrics;    Diabetic retinopathy;    Diabetes complications;    Diabetes mellitus;   

Others  :  1220759
DOI  :  10.1186/s13098-015-0054-z

 received in 2015-03-26, accepted in 2015-06-17,  发布年份 2015

【 摘 要 】

Background

We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States.

Methods

236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history.

Results

Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired.

Conclusions

Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high.

【 授权许可】

   
2015 Tapley et al.

【 参考文献 】

• [1]Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al.: Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001–2009. JAMA 2014, 311:1778-86.
• [2]American Diabetes Association: Standards of medical care in diabetes – 2014 Diabetes Care 2014, 37(Suppl 1):S14-S80.
• [3]Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984, 102:520-6.
• [4]Fong DS, Aiello LM, Gardner TW, King GI, Blankenship G, Cavallerano JD, et al.: Retinopathy in diabetes. Diabetes Care 2004, 27(Suppl):S84-S7.
• [5]Raczynska D, Zorena K, Urban B, Zaleski D, Slorek A, Maulkiewicz G, et al.: Current trends in the monitoring and treatment of diabetic retinopathy in young adults. Mediators Inflamm 2014, 2014:492926.
• [6]Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy: ETDRS report number 9 Ophthalmology 1991, 98(Suppl):766-85.
• [7]Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: diabetic retinopathy vitrectomy study report 5. Arch Ophthalmol. 1990;108:958–64.
• [8]Hamman RF, Bell RA, Dabelea D, D’Agostino RBJ, Dolan L, Imperatore G, et al.: The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care 2014, 37:3336-44.
• [9]Waitzfelder B, Pihoker C, Klingensmith G, Case D, Anderson AJ, Bell RA, et al.: Adherence to guidelines for youths with diabetes mellitus. Pediatrics 2011, 128:531-8.
• [10]Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM: The sensitivity and specificity of single-field monmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 2002, 134:204-13.
• [11]Massin P, Erginay A, Mehidi AB, Vicaut E, Quentel G, Victor Z, et al.: Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med 2003, 20:635-41.
• [12]Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR: Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol 2011, 129:435-44.
• [13]Stillman JK, Gole GA, Wootton R, Woolfield N, Price D, Van der Westhuyzen J, et al.: Telepaediatrics and diabetic retinoapthy screening of young people with diabetes in Queensland. J Telemed Telecare 2004, 10(Suppl):92-4.
• [14]Kolomeyer AM, Nayak NV, Simon MA, Szirth BC, Shahid K, Sheng IY, et al.: Feasibility of retinal screening in a pediatric population with type 1 diabetes. J AAPOS 2014, 51:299-306.
• [15]Minuto N, Emmanuele V, Vannati M, Russo C, Rebora C, Panarello S, Pistorio A, et al.: Retinopathy screening in patients with type 1 diabetes diagnosed in young age using non-mydriatic digital sterescopic retinal imaging. J Endocrinol Invest 2012, 35:389-94.
• [16]Alabama Department of Public Health. Diabetes in Alabama. Alabama Department of Public Health, Montgomery, AL 2010. https://adph.org/diabetes/assets/DiabetesinALReport09.pdf. Accessed 23 Mar 2015.
• [17]Harding SP, Greenwood R, Adlington S, Gibson J, Owens DA, Talylor R, et al.: Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003, 20:965-71.
• [18]American Academy of Ophthalmology Preferred Practice Patterns Committee. Preferred Practice Pattern Guidelines. Comprehensive Adult Medical Eye Evaluation 2010. American Academy of Ophthalmology, San Francisco CA. http://www.aao.org/preferred-practice-pattern/comprehensive-adult-medical-eye-evaluation--octobe. Accessed 23 June 2015.
• [19]Daniels SR, Greer FR: Lipid screening and cardiovascular health in childhood. Pediatrics 2008, 122:198-208.
• [20]Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al.: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011, 34:e61-e99.
• [21]Peters A, Davidson MB, Ziel FH: Cost-effective screening for diabetic retinopathy using a nonmydriatic reitnal camera in a prepaid health-care setting. Diabetes Care 1993, 16:1193-5.
• [22]Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Garned N, et al.: The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabet Med 2003, 20:467-74.
• [23]Scanlon PH, Foy C, Malhotra R, Aldington SJ: The influence of age, duration of diabetes, cataract, and pupil size on image quaity in digital photographic retinal screening. Diabetes Care 2005, 28:2448-53.
• [24]Valent D, Pestak K, Otis M, Shubrook J: Type 2 diabetes in the pediatric population: are we meeting ADA clinical guidelines in Ohio. Clin Pediatr 2010, 49:316-22.
• [25]Dumser SM, Ratcliffe SJ, Langdon DR, Murpphy KM, Lipman TH: Racial disparities in screening for diabetic retinopathy in you with type 1 diabetes. Diabetes Res Clin Pract 2013, 101:e3-e5.
• [26]Schoenfeld ER, Greene JM, Wu SY, Leske C: Patterns of adherence to diabetes vision care guidelines. Ophthalmology 2001, 108:563-71.
• [27]Rosenberg JB, Friedman IB, Gurland JE: Compliance with screening guidelines fo diabetic retinopathy in a large academic children’s hospital in the Bronx. J Diabetes Complications 2011, 25:222-6.
• [28]Scanlon PH: The English National Screening Programme for sight threatening retinopathy. J Med Screen 2008, 15:1-4.
• [29]Jones S, Edwards RT: Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2010, 27:249-56.
• [30]Huo B, Steffen AT, Swan K, Sikes K, Weinzimer SA, Tamborlane WV: Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes. Diabetes Care 2007, 30:362-3.
• [31]Lueder GT, Silverstein J: Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics 2005, 116:270-3.
• [32]Donaghue KC, Fairchild JM, Chan A, Hing SJ, King J, Howard NJ, et al.: Diabetes microvascluar complications in prepubertal children. J Pediatr Endocrinol Metab 1997, 10:579-85.
• [33]Holl RW, Lang A, Grabert M, Heinze E, Lang GK, Debatin KM: Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr 1998, 132:790-4.
• [34]Forlenza GP, Steward MW: Diabetic retinopathy in children. Pediatr Endocrinol Rev 2012, 10:217-26.